ORMP
Oramed Pharmaceuticals, Inc

4,676
Mkt Cap
$125.38M
Volume
277,365.00
52W High
$3.24
52W Low
$1.82
PE Ratio
3.14
ORMP Fundamentals
Price
$3.15
Prev Close
$2.95
Open
$2.99
50D MA
$2.58
Beta
0.52
Avg. Volume
268,661.89
EPS (Annual)
-$0.4668
P/B
0.63
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
Oramed Reports Fiscal Third Quarter 2025 Financial Results
Oramed Reports Fiscal Third Quarter 2025 Financial Results Oramed Reports Fiscal Third Quarter 2025 Financial Results PR Newswire NEW YORK, Nov. 17, 2025 Strong Nine-Month Performance Driven by...
PR Newswire·1mo ago
News Placeholder
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS PR Newswire NEW...
PR Newswire·1mo ago
News Placeholder
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives Oramed Releases Letter to...
PR Newswire·2mo ago
<
...
1
>

Latest ORMP News

View

Advertisement|Remove ads.

Advertisement|Remove ads.